FDA Clearance Tracker · K231362
OCS Heart Leukocyte Depleting Filter
Last checked: Nov 20, 2026Latest source record: Oct 31, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Oct 31, 2023
Substantially Equivalent
Time to decision
173 days
Received May 11, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K231362
- Device name
- OCS Heart Leukocyte Depleting Filter
- Applicant
- TransMedics, Inc.
- Applicant location
- Andover, MA
- Received
- May 11, 2023
- Decided
- Oct 31, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.4260
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DTM. The earliest in FDA's data is K781707, decided Oct 26, 1978.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K231362
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for TransMedics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- OCS Lung Donor Flush Set510(k)
K222535 · Decided Nov 18, 2022 · 88 days after receipt
Device type: System And Accessories, Isolated Heart, Transport And Preservation (MSB) · GI, Urology & Nephrology
- OCS Heart SystemBreakthroughPMA supplement
P180051-S001 · Decided Apr 27, 2022 · 170 days after receipt · Panel Track
Device type: Organ care system (OCS) heart system (QIK) · Cardiology
P200031 · Decided Sep 28, 2021 · 455 days after receipt
Device type: Normothermic machine perfusion system for the preservation of donor livers prior to transplantation (QQK) · GI, Urology & Nephrology
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.